Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 106, Issue 1, Pages 99-106
Publisher
Springer Nature
Online
2012-01-04
DOI
10.1038/bjc.2011.530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress-related proteins in a Conn’s adenoma tissue. Relevance for aldosterone’s prooxidative and proinflammatory activity
- (2014) L. A. Calò et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells
- (2012) Yi Wang Medicinal Chemistry
- Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
- (2011) Paula Vainio et al. AMERICAN JOURNAL OF PATHOLOGY
- Salinomycin Selectively Targets ‘CD133+’ Cell Subpopulations and Decreases Malignant Traits in Colorectal Cancer Lines
- (2011) Tao-Tao Dong et al. ANNALS OF SURGICAL ONCOLOGY
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Therapeutics formulated to target cancer stem cells: Is it in our future?
- (2011) Stephanie Clayton et al. Cancer Cell International
- Regulation of reactive oxygen species in stem cells and cancer stem cells
- (2011) Chiharu I. Kobayashi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
- (2011) Vinagolu K. Rajasekhar et al. Nature Communications
- Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
- (2010) Dominik Fuchs et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
- (2010) Ju-Hwa Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species
- (2010) Y. Jin et al. CANCER RESEARCH
- Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
- (2010) Jianghua Wang et al. CANCER RESEARCH
- High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
- (2010) Christel van den Hoogen et al. CANCER RESEARCH
- Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells
- (2010) K. Ketola et al. MOLECULAR CANCER THERAPEUTICS
- Aldosterone induces oxidative stress, oxidative DNA damage and NF-κB-activation in kidney tubule cells
- (2010) Nina Queisser et al. MOLECULAR CARCINOGENESIS
- Progesterone induces adult mammary stem cell expansion
- (2010) Purna A. Joshi et al. NATURE
- Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential
- (2010) Asha Acharya et al. Oxidative Medicine and Cellular Longevity
- β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor
- (2010) Udi Gluschnaider et al. PLoS One
- Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
- (2009) Dominik Fuchs et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oxidative stress in prostate cancer
- (2009) Lakshmipathi Khandrika et al. CANCER LETTERS
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
- (2009) George J. Klarmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Nuclear Factor- B-Mediated Transforming Growth Factor- -Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy
- (2009) Q. Zhang et al. CLINICAL CANCER RESEARCH
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details
- (2009) Richard L Auten et al. PEDIATRIC RESEARCH
- Molecular Signatures of Prostate Stem Cells Reveal Novel Signaling Pathways and Provide Insights into Prostate Cancer
- (2009) Roy Blum et al. PLoS One
- High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells
- (2009) Patricia E. Burger et al. STEM CELLS
- The Nuclear Factor- B Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth
- (2008) R. J. Jin et al. CANCER RESEARCH
- NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases
- (2008) Fazlul H. Sarkar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Aldehyde Dehydrogenase as a Marker for Stem Cells
- (2008) Jan Moreb Current Stem Cell Research & Therapy
- Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
- (2008) Richard Birnie et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started